Robuta

https://www.prnewswire.com/news-releases/bio-thera-and-dr-reddys-execute-exclusive-commercialization-agreement-for-bat2206-a-proposed-stelara-biosimilar-and-bat2506-a-proposed-simponi-biosimilar-for-southeast-asia-302413367.html Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed... /PRNewswire/ -- Bio-Thera Solutions (688177:SH; "Bio-Thera"), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and...